Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Emeline Bollaert"'
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-7 (2022)
Abstract Somatic point mutations of the FOXO1 transcription factor were reported in non-Hodgkin lymphoma including diffuse large B-cell lymphoma, follicular lymphoma and Burkitt lymphoma. These alterations were associated with a poor prognosis and re
Externí odkaz:
https://doaj.org/article/b2bb925e220f47229c85166c558a5977
Autor:
Emeline Bollaert, Melissa Claus, Virginie Vandewalle, Sandrine Lenglez, Ahmed Essaghir, Jean-Baptiste Demoulin, Violaine Havelange
Publikováno v:
International Journal of Molecular Sciences, Vol 22, Iss 10, p 5153 (2021)
Anthracyclines remain a cornerstone of induction chemotherapy for acute myeloid leukemia (AML). Refractory or relapsed disease due to chemotherapy resistance is a major obstacle in AML management. MicroRNAs (miRNAs) have been observed to be involved
Externí odkaz:
https://doaj.org/article/506712b71b0945a098ecd2a0d6e3b994
Autor:
Hélène Schoemans, Lucienne Michaux, Pascale Saussoy, Sandrine Lenglez, Emeline Bollaert, Violaine Havelange, Virginie Vandewalle, Ahmed Essaghir, Carlos Graux, Peter J. M. Valk, Jean-Baptiste Demoulin
Publikováno v:
Journal of cellular and molecular medicine, Vol. 25, no. 1, p. 575-585 (2021)
Journal of Cellular and Molecular Medicine
Journal of Cellular and Molecular Medicine, 25(1), 575-585. Wiley-Blackwell Publishing Ltd
Journal of Cellular and Molecular Medicine
Journal of Cellular and Molecular Medicine, 25(1), 575-585. Wiley-Blackwell Publishing Ltd
Cytarabine and daunorubicin are old drugs commonly used in the treatment of acute myeloid leukaemia (AML). Refractory or relapsed disease because of chemotherapy resistance is a major issue. microRNAs (miRNAs) were incriminated in resistance. This st
Autor:
Jean-Baptiste Demoulin, Melissa Claus, Emeline Bollaert, Ahmed Essaghir, Violaine Havelange, Virginie Vandewalle, Sandrine Lenglez
Publikováno v:
International Journal of Molecular Sciences
Volume 22
Issue 10
International journal of molecular sciences, Vol. 22, no.10, p. 5153 (2021)
International Journal of Molecular Sciences, Vol 22, Iss 5153, p 5153 (2021)
Volume 22
Issue 10
International journal of molecular sciences, Vol. 22, no.10, p. 5153 (2021)
International Journal of Molecular Sciences, Vol 22, Iss 5153, p 5153 (2021)
Anthracyclines remain a cornerstone of induction chemotherapy for acute myeloid leukemia (AML). Refractory or relapsed disease due to chemotherapy resistance is a major obstacle in AML management. MicroRNAs (miRNAs) have been observed to be involved
Autor:
Gaëtan Herinckx, Emeline Bollaert, Virginie Vandewalle, Audrey de Rocca Serra, Manuel Johanns, Mark H. Rider, Jean-Baptiste Demoulin, Didier Vertommen, Violaine Havelange
Publikováno v:
Cellular Signalling. 44:158-170
The HMG-box protein 1 (HBP1) is a transcriptional regulator and a potential tumor suppressor that controls cell proliferation, differentiation and oncogene-mediated senescence. In a previous study, we showed that AKT activation through the PI3K/AKT/F
Publikováno v:
Cellular and Molecular Life Sciences, (2019)
HMG box protein 1 (HBP1) is a transcription factor and a potent cell cycle inhibitor in normal and cancer cells. HBP1 activates or represses the expression of different cell cycle genes (such as CDKN2A, CDKN1A, and CCND1) through direct DNA binding,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9a984d832b9fdcdce69608660ac14420
https://hdl.handle.net/2078.1/211250
https://hdl.handle.net/2078.1/211250
Autor:
Fanélie, Jouenne, Isaure, Chauvot de Beauchene, Emeline, Bollaert, Marie-Françoise, Avril, Olivier, Caron, Olivier, Ingster, Axel, Lecesne, Patrick, Benusiglio, Philippe, Terrier, Vincent, Caumette, Daniel, Pissaloux, Arnaud, de la Fouchardière, Odile, Cabaret, Birama, N'Diaye, Amélie, Velghe, Gaelle, Bougeard, Graham J, Mann, Serge, Koscielny, Jennifer H, Barrett, Mark, Harland, Julia, Newton-Bishop, Nelleke, Gruis, Remco, Van Doorn, Marion, Gauthier-Villars, Gaelle, Pierron, Dominique, Stoppa-Lyonnet, Isabelle, Coupier, Rosine, Guimbaud, Capucine, Delnatte, Jean-Yves, Scoazec, Alexander M, Eggermont, Jean, Feunteun, Luba, Tchertanov, Jean-Baptiste, Demoulin, Thierry, Frebourg, Brigitte, Bressac-de Paillerets
Publikováno v:
Journal of medical genetics. 54(9)
Sarcomas are rare mesenchymal malignancies whose pathogenesis is poorly understood; both environmental and genetic risk factors could contribute to their aetiology.We performed whole-exome sequencing (WES) in a familial aggregation of three individua
Autor:
Gaëlle Pierron, Gaëlle Bougeard, Jean-Baptiste Demoulin, Axel Lecesne, Daniel Pissaloux, Emeline Bollaert, Thierry Frebourg, Brigitte Bressac-de Paillerets, Serge Koscielny, Capucine Delnatte, Jean-Yves Scoazec, Isaure Chauvot de Beauchêne, Jennifer H. Barrett, Philippe Terrier, Arnaud de la Fouchardière, Graham J. Mann, Isabelle Coupier, Nelleke A. Gruis, Jean Feunteun, Birama N’Diaye, Alexander M.M. Eggermont, Dominique Stoppa-Lyonnet, Olivier Ingster, Luba Tchertanov, Rosine Guimbaud, Patrick R. Benusiglio, Olivier Caron, Fanélie Jouenne, Marie-Françoise Avril, Marion Gauthier-Villars, Remco van Doorn, Julia Newton-Bishop, Vincent Caumette, Mark Harland, Amélie Velghe, Odile Cabaret
Publikováno v:
BASE-Bielefeld Academic Search Engine
Journal of Medical Genetics
Journal of Medical Genetics, BMJ Publishing Group, 2017, 54 (9), pp.607-612. ⟨10.1136/jmedgenet-2016-104402⟩
Journal of Medical Genetics, BMJ Publishing Group, 2017, 〈10.1136/jmedgenet-2016-104402〉
Journal of Medical Genetics, 54(9), 607-612
Daniel PISSALOUX
Journal of Medical Genetics, 2017, 54 (9), pp.607-612. ⟨10.1136/jmedgenet-2016-104402⟩
Journal of Medical Genetics
Journal of Medical Genetics, BMJ Publishing Group, 2017, 54 (9), pp.607-612. ⟨10.1136/jmedgenet-2016-104402⟩
Journal of Medical Genetics, BMJ Publishing Group, 2017, 〈10.1136/jmedgenet-2016-104402〉
Journal of Medical Genetics, 54(9), 607-612
Daniel PISSALOUX
Journal of Medical Genetics, 2017, 54 (9), pp.607-612. ⟨10.1136/jmedgenet-2016-104402⟩
International audience; BACKGROUND: Sarcomas are rare mesenchymal malignancies whose pathogenesis is poorly understood; both environmental and genetic risk factors could contribute to their aetiology.METHODS AND RESULTS: We performed whole-exome sequ
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2b4697f70271b5a9449ed5dc9a35c29c
https://hal.archives-ouvertes.fr/hal-02355798
https://hal.archives-ouvertes.fr/hal-02355798